Chen; Ming J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chen; Ming J..The latest application filed is for "pharmaceutical compositions comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- l)benzyl)piper".

Company Profile

1.16.10

Chen; Ming J. - West Windsor NJ
Chen; Ming J. - Garnerville NY
Chen; Ming J. - Valley Cottage NY
Chen; Ming J. - Sanchung City Taipei Hsien TW
Chen; Ming J. - Taipei TW

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Compositions Comprising (s)-4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methy- L)benzyl)piper App 20200215061 - Agrawal; Anjali ; et al.	2020-07-09
Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3- -dihydro-1H-isoindol-4-yl}-amide Grant 9,757,355 - Chen , et al. September 12, 2	2017-09-12
Nanosuspension of a poorly soluble drug via microfluidization process Grant 9,616,019 - Chen , et al. April 11, 2	2017-04-11
Controlled release oral dosage forms of poorly soluble drugs and uses thereof Grant 9,532,977 - Chen , et al. January 3, 2	2017-01-03
Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]p- yrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use Grant 9,434,735 - Chen , et al. September 6, 2	2016-09-06
Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof App 20160128981 - CHEN; Ming J. ; et al.	2016-05-12
Amorphous Form Of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]p- Yrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, Compositions Thereof And Methods Of Their Use App 20160009722 - CHEN; Ming J. ; et al.	2016-01-14
Nanosuspension Of A Poorly Soluble Drug Via Microfluidization Process App 20150265534 - CHEN; Ming J. ; et al.	2015-09-24
Nanosuspension of a poorly soluble drug via microfluidization process Grant 9,023,886 - Chen , et al. May 5, 2	2015-05-05
Oral Dosage Forms Of Cyclopropanecarboxylic Acid -amide App 20140093561 - Chen; Ming J. ; et al.	2014-04-03
Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof App 20140018404 - Chen; Ming J. ; et al.	2014-01-16
Nanosuspension of a Poorly Soluble Drug via Microfluidization Process App 20110124702 - CHEN; Ming J. ; et al.	2011-05-26
Polyisocyanate composition of low viscosity having a high functionality and preparation process Grant 6,730,405 - Bernard , et al. May 4, 2	2004-05-04
Polyisocyanate composition of low viscosity having a high functionality and preparation process App 20030096909 - Bernard, Jean-Marie ; et al.	2003-05-22
Aqueous silylated polymer curable compositions Grant 6,069,200 - Chen , et al. May 30, 2	2000-05-30
Aqueous silylated polymer curable compositions with tin catalysts Grant 5,827,922 - Chen , et al. October 27, 1	1998-10-27
Composition of epoxysilane emulsion additives in water based reactive polymer dispersions and methods of preparation Grant 5,714,532 - Osterholtz , et al. February 3, 1	1998-02-03
Aqueous curable silane/polymer compositions Grant 5,686,523 - Chen , et al. November 11, 1	1997-11-11
Aqueous silylated polymer curable compositions Grant 5,621,038 - Chen , et al. April 15, 1	1997-04-15
Cationic emulsions of alkylalkoxysilanes Grant 5,393,330 - Chen , et al. February 28, 1	1995-02-28
Mechanics creeper Grant 5,297,809 - Chen March 29, 1	1994-03-29
Mechanics creeper Grant D325,799 - Chen April 28, 1	1992-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.